MENU
VRNA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Verona Pharma (VRNA) Ownership - Who owns Verona Pharma?

Profile

Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.34B
P/E Ratio
N/A
Total Cash
404.6M
Projected Growth
N/A
Total Debt
122.2M
Revenue
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash/Share
4.98
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

VRNA
Capitalization
2.34B
P/E Ratio
N/A
Risk (Beta)
-0.10
Dividend Yield
N/A
Total Cash
405M
Total Cash/Share
4.98
Total Debt
122M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
168M
P/B Ratio
13.89
Cash Flow
N/A
Earnings
-1.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
42.8M
Current Ratio
8.61
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-118.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.99
Shares Held By Institutions
1.31B
Shares Outstanding - Current
81.2M
Total Liabilities
266M
Total Volume MTD
N/A
Value
-1
Gain YTD
66.549
View a ticker or compare two or three
VRNA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com